Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

November 18, 2023
< 1 mins

Category: Published research
Product: NeuroQuant MS
Disease: Multiple sclerosis

This study compares clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. 2012.

[button]Download[/button]

Topic: Published research

More Resources

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

Cortechs.ai news

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

Case studies

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

Product updates

07/16/2025

Advancing Prostate MRI with Restriction Spectrum Imaging

Why is OnQ Prostate unique, and what makes it a game-changer for clinicians?

Product updates

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.

Product updates

07/07/2025

When to repeat an MRI scan for NeuroQuant^®

NeuroQuant^® can process an array of exams. However, there are some circumstances that will require you to repeat a scan.

Our solutions

Our solutions

About

Support

Resources